# BOSTON SCIENTIFIC CORPORATION (BSX) FY2025 Annual Balance Sheet

- Company: BOSTON SCIENTIFIC CORPORATION (BSX)
- Period: As of 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-17, accession number 0000885725-26-000010
- Page: https://plicit.ai/financials/bsx/fy2025-annual-balance-sheet
- Chart image: https://plicit.ai/charts/bsx-fy2025-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 43,673,000,000 US dollars
- **Current assets**: 8,794,000,000 US dollars
- **Non-current assets**: 34,879,000,000 US dollars
- **Liabilities (calculated)**: 19,201,000,000 US dollars
- **Current liabilities**: 5,439,000,000 US dollars
- **Non-current liabilities**: 13,762,000,000 US dollars
- **Equity**: 24,472,000,000 US dollars
- **Noncontrolling interest**: 239,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Inventories**: 2,943,000,000 US dollars
- **Trade accounts receivable, net**: 2,926,000,000 US dollars
- **Cash and cash equivalents**: 1,965,000,000 US dollars
- **Other current assets**: 660,000,000 US dollars
- **Prepaid income taxes**: 299,000,000 US dollars
- **Goodwill**: 18,282,000,000 US dollars
- **Other intangible assets, net**: 7,019,000,000 US dollars
- **Property, plant and equipment, net**: 4,036,000,000 US dollars
- **Deferred tax assets**: 3,675,000,000 US dollars
- **Other long-term assets**: 1,866,000,000 US dollars
- **Accrued expenses**: 3,201,000,000 US dollars
- **Accounts payable**: 1,144,000,000 US dollars
- **Other current liabilities**: 795,000,000 US dollars
- **Current debt obligations**: 299,000,000 US dollars
- **Long-term debt**: 11,137,000,000 US dollars
- **Other long-term liabilities**: 2,405,000,000 US dollars
- **Deferred tax liabilities**: 220,000,000 US dollars
- **Additional paid-in capital**: 21,505,000,000 US dollars
- **Retained earnings**: 5,571,000,000 US dollars
- **Common stock, $0.01 par value - authorized 2,000,000,000 shares; 1,746,290,165 shares issued as of December 31, 2025 and 1,737,846,196 shares issued as of December 31, 2024**: 17,000,000 US dollars
- **Preferred stock, $0.01 par value - authorized 50,000,000 shares; 0 shares issued as of December 31, 2025 and 2024**: 0 US dollars
- **Noncontrolling interests**: 239,000,000 US dollars
- **Treasury stock, at cost - 263,289,848 shares as of December 31, 2025 and 2024**: negative 2,251,000,000 US dollars
- **Accumulated other comprehensive income (loss), net of tax**: negative 610,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
- The filed current assets lines add up to $8,793.00 M and the current assets total is $8,794.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed non-current assets lines add up to $34,878.00 M and the non-current assets total is $34,879.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed equity lines add up to $24,471.00 M and the equity total is $24,472.00 M; the $1.00 M difference is within the rounding of the filed amounts.